Affera Global Registry

NCT06026345 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 540

Last updated 2025-10-07

No results posted yet for this study

Summary

The Affera Global Registry is a prospective, global, multi-center, observational post-market registry (PMR). The purpose of this study is to describe clinical performance and safety data in a broad patient population treated with the Affera Platform.

Conditions

Interventions

DEVICE

Affera Platform

A cardiac ablation will be performed using the Affera Platform

Sponsors & Collaborators

  • Medtronic Cardiac Ablation Solutions

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-12-22
Primary Completion
2028-04-01
Completion
2028-07-01

Countries

  • Belgium
  • Czechia
  • France
  • Germany
  • Ireland
  • Switzerland
  • United Kingdom

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06026345 on ClinicalTrials.gov